Effects of Inhaled Corticosteroid/Long-Acting b2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease
- Alternative Title
- Effects of Inhaled Corticosteroid/Long-Acting b2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease
- Abstract
- Fluticasone-based ICS/LABA therapy modifies the airway microbiome in COPD, leading to a relative reduction in a-diversity and a greater number of bacterial taxa changes. These data may have implications in patients who develop pneumonia on ICS.
- Issued Date
- 2021
- Type
- Article
- URI
- https://oak.ulsan.ac.kr/handle/2021.oak/7241
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_journals_2604511718&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,Effects%20of%20Inhaled%20Corticosteroid%2FLong-Acting%20b2-Agonist%20Combination%20on%20the%20Airway%20Microbiome%20of%20Patients%20with%20Chronic%20Obstructive%20Pulmonary%20Disease&offset=0&pcAvailability=true
- Publisher
- AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Location
- 미국
- Language
- 영어
- ISSN
- 1073-449X
- Citation Volume
- 204
- Citation Number
- 10
- Citation Start Page
- 1143
- Citation End Page
- 1152
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.